Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Medtronic landed a significant win with the announcement of an FDA win for its Resolute Integrity drug-eluting stent, the first device on the U.S. market cleared for patients with coronary artery disease as well as diabetes.
Diabetic patients make up about ⅓ of all those with CAD, and they represent a difficult-to-treat population.
"They tend to have smaller and often tortuous arteries, longer lesions, diffuse disease and a higher rate of treatment failures including relatively high rates of repeat procedures and stent thrombosis," Medtronic told MassDevice in an email. "As a result, many of these patients have undergone open heart surgery."
http://www.massdevice.com/news/diabetes-medtronic-lands-clearance-first-heart-stent-diabetics-0
Diabetic patients make up about ⅓ of all those with CAD, and they represent a difficult-to-treat population.
"They tend to have smaller and often tortuous arteries, longer lesions, diffuse disease and a higher rate of treatment failures including relatively high rates of repeat procedures and stent thrombosis," Medtronic told MassDevice in an email. "As a result, many of these patients have undergone open heart surgery."
http://www.massdevice.com/news/diabetes-medtronic-lands-clearance-first-heart-stent-diabetics-0